cyvitria AG

The company aims to discover and develop new active substances (medicines). The company may establish branches and subsidiaries in Switzerland and abroad, participate in other companies in Switzerland and abroad, and conduct all business directly or indirectly related to its purpose. The company may also provide financing for its own account or for the account of third parties, as well as enter into security transactions, including guarantees, pledges, global assignments, security transfers, and indemnification agreements, for affiliated companies and third parties, even if these are in their exclusive interest.